Showing results (51-60 of 73) with videos related to
Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2023
HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-ResistanceSimone Stupia, Christina Heeke, Alicia Brüggemann, et al.NAR Genomics and Bioinformatics|January 19, 2026
SyMetrics: an integrated machine learning model for evaluating the pathogenicity of synonymous variants in the human genomeLinnaeus Bundalian, Martina Schmidt Strnadová, Felix Garten, et al.Oncotarget|September 2, 2015
Analysis of SDHD promoter mutations in various types of melanomaSimone L Scholz, Susanne Horn, Rajmohan Murali, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Genetic evolution of T-cell resistance in the course of melanoma progressionAntje Sucker, Fang Zhao, Birgit Real, et al.Cell Reports|June 24, 2023
PTK7 is a positive allosteric modulator of GPR133 signaling in glioblastomaJoshua D Frenster, Hediye Erdjument-Bromage, Gabriele Stephan, et al.European Journal of Cancer (Oxford, England : 1990)|March 27, 2021
Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphologyAnne Zaremba, Georg Lodde, Rajmohan Murali, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 29, 2021
The genetic landscape of intellectual disability and epilepsy in adults and the elderly: a systematic genetic work-up of 150 individualsPia Zacher, Thomas Mayer, Frank Brandhoff, et al.Journal of Neuro-Oncology|January 9, 2016
Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous systemJohannes van de Nes, Marco Gessi, Antje Sucker, et al.Cancers|September 9, 2022
Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic LesionsAnne Zaremba, Philipp Jansen, Rajmohan Murali, et al.Nature Communications|June 1, 2017
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesionsAntje Sucker, Fang Zhao, Natalia Pieper, et al.Pageof 8